Acompanhe as Notícias da Recifes

Airline’s board minded to recommend deal – after accepting rival one from Castlelake earlier this weekBusiness live – latest updatesThe board of easyJet has given the green light to a possible £5.7bn offer from the US private equity firm Apollo, as the low-cost airline becomes the subject of a surprise bidding war.The company’s board said on Friday that it was “minded to recommend” the potential all-cash offer, which values the business at £7.15 a share, to shareholders. Continue readi

Gigs by Gallagher brothers, Coldplay, Lana Del Rey and Beyonce gives £11bn boost to the economyBig name artists including Oasis with their highly anticipated reunion tour, Coldplay and Beyoncé helped to attract a record number of fans to travel to watch live music last year, helped by a surge in overseas visitors at UK gigs.A report from the industry body UK Music estimated that 24.7 million “music tourists” attended concerts and festivals last year, up 4.8% on 2024, leading to an unpr

Questions swirl about origins of gifts, loans and donations as even party supporters wonder if it can weather the stormUK politics live – latest updatesWhy is Farage quitting as an MP, only to stand again?Scrutiny is mounting on Reform UK’s finances.On Tuesday, amid an investigation by parliamentary standards into an undisclosed £5m gift, Nigel Farage announced he would resign and trigger a byelection in his constituency of Clacton-on-Sea. Continue reading...

Business secretary Peter Kyle says asset managers should feel a patriotic duty to make the UK a successBusiness live – latest updatesThe business secretary, Peter Kyle, has warned UK pension funds to “get off their high horses” and invest in Britain or be forced to do so by law.Expressing frustration at the level of investment in British companies after years of government initiatives, Kyle said the UK’s biggest asset managers “should feel a patriotic duty in making Britain a success”.

Brent crude dips slightly below $78 a barrel; most Asian stock markets bounce backBritain’s second-biggest drugmaker GSK has also taken a hit from recent drug failures.The Californian biotech Alector has said that GSK has ended their neuroscience collaboration covering ​two experimental antibody drugs, after both drug candidates suffered setbacks in clinical trials.The CARDIO-TTRansform trial was designed to examine the role of Wainua, a gene silencer treatment, on top of today’s stand